Grand Pharmaceutical Group Limited Stock OTC Markets
Stocks
CGPHF
BMG210A71016
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 06-05 | Grand Pharmaceutical Group Limited Declares Final Dividend for the Year Ended 31 December 2025 | CI |
| 04-13 | Grand Pharmaceutical Says Liver Cancer Treatment Reaches Clinical Endpoint | MT |
| Market Cap | 17.68B 2.26B 1.95B 1.8B 1.68B 3.15B 215B 3.2B 21.21B 8.27B 104B 8.47B 8.29B 362B | P/E Ratio 2026 * |
9.35x | P/E Ratio 2027 * | 8.61x |
|---|---|---|---|---|---|
| Enterprise Value | 17.68B 2.26B 1.95B 1.8B 1.68B 3.15B 215B 3.2B 21.21B 8.27B 104B 8.47B 8.29B 362B | EV / Sales 2026 * |
1.31x | EV / Sales 2027 * | 1.2x |
| Free-Float |
23.76% | Yield 2026 * |
4.75% | Yield 2027 * | 5.54% |
| Manager | Title | Age | Since |
|---|---|---|---|
Chao Zhou
CEO | Chief Executive Officer | 36 | 2021-05-31 |
Tin Chung Foo
SEC | Corporate Secretary | 57 | 2011-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Tosi Wan So
BRD | Director/Board Member | 63 | 2010-02-24 |
Ye Bi Hu
BRD | Director/Board Member | 62 | 2018-12-30 |
Geng Pei
BRD | Director/Board Member | 66 | 2011-05-11 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 2.26B | |
| -2.41% | +0.14% | +38.28% | +154.20% | 1,010B | |
| +1.07% | +3.48% | +53.32% | +49.85% | 580B | |
| +1.32% | +0.22% | +19.18% | +64.65% | 402B | |
| +0.77% | 0.00% | +21.28% | +16.70% | 330B | |
| +0.44% | +3.48% | +25.65% | +35.66% | 281B | |
| -0.85% | -2.86% | +22.54% | +14.67% | 280B | |
| +1.66% | +1.20% | -44.35% | -47.35% | 197B | |
| +0.32% | +1.61% | +20.32% | +60.01% | 192B | |
| -0.22% | -2.76% | +14.19% | +60.09% | 156B | |
| Average | +0.21% | +0.84% | +18.93% | +45.39% | 380.99B | |
| Weighted average by Cap. | -0.23% | +1.04% | +27.77% | +70.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.47B 1.72B 1.48B 1.37B 1.28B 2.4B 163B 2.44B 16.15B 6.3B 79.53B 6.45B 6.31B 275B | 14.78B 1.89B 1.63B 1.5B 1.41B 2.63B 179B 2.67B 17.73B 6.91B 87.28B 7.08B 6.93B 302B |
| Net income | 1.91B 244M 211M 194M 182M 341M 23.2B 346M 2.29B 894M 11.29B 916M 897M 39.1B | 2.09B 266M 230M 212M 198M 372M 25.3B 377M 2.5B 975M 12.32B 999M 978M 42.64B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 512 Stock
- CGPHF Stock
Select your edition
All financial news and data tailored to specific country editions
